etoposide has been researched along with Hand-Schu00FCller-Christian Disease in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.28) | 18.7374 |
1990's | 34 (55.74) | 18.2507 |
2000's | 16 (26.23) | 29.6817 |
2010's | 9 (14.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bihl, M; Haefliger, S; Krasniqi, F; Tzankov, A | 1 |
Minkov, M | 1 |
A Al Hamad, M; A Shawarby, M; Al Saeed, WR; Albisher, HM; Allabbad, FM; Almumtin, AT | 1 |
Cai, HC; Cao, XX; Chen, M; Duan, MH; Han, B; Han, X; Li, J; Wang, SJ; Yang, C; Zhang, W; Zhou, DB; Zhu, TN; Zhuang, JL | 1 |
Belaïch, H; Gentet, JC; Michel, G; Nicollas, R; Roman, S; Rome, A; Triglia, JM; Volk, M | 1 |
Li, R; Tu, P; Wang, X; Yang, S | 1 |
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T | 1 |
Adam, Z; Adamová, Z; Brejcha, M; Hájek, R; Kodet, R; Koukalová, R; Krejčí, M; Mayer, J; Moulis, M; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L | 1 |
Campisi, G; Deli, G; Giuliani, M; Guiglia, R; Lajolo, C; Littarru, C | 1 |
Gadner, H; Grois, N; Heitger, A; Minkov, M; Pötschger, U; Westermeier, T | 1 |
Braier, JL; Diez, RA; Ripoli, MF; Rosso, DA; Roy, A; Zelazko, ME | 1 |
Otis, CN; Powell, JL | 1 |
Chánová, M; Ganevová, M; Kodet, R; Mottl, H; Mrhalová, M; Radvanská, J; Smelhaus, V; Tichý, M | 1 |
Attarbaschi, A; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Minkov, M; Mittheisz, E; Steiner, M; Zoubek, A | 1 |
Betsuyaku, T; Hizawa, N; Koizumi, T; Konno, S; Nishimura, M; Yamamoto, H; Yasuo, M | 1 |
Abderrahmane, K; Boukhris, I; Ghorbel, IB; Houman, MH; Kchir, MN; Khanfir, M; Lamloum, M; Miled, M | 1 |
Castel, V; Esquembre, C; Ferris, J; López-Andreu, JA; Verdeguer, A | 1 |
Inamitsu, T; Ishii, E; Matsuzaki, A; Nagotoshi, Y; Ohga, S; Suda, M; Tasaka, H; Ueda, K; Watanabe, T | 1 |
Aricó, M; Broadbent, V; Gadner, H; Jakobson, A; Komp, D; Ladisch, S; Nicholson, S | 1 |
Shenoy, S; Ward, K; Warrier, RP; Yu, LC | 1 |
Gadner, H; Ladisch, S | 1 |
Smith, PJ; Souès, S | 1 |
Arceci, RJ | 1 |
Cingil, H; Doğan, B; Harmanyeri, Y; Oztek, I; Sayrak, H | 1 |
Drouin, V; Fusade, T; Kanold, J; Prudent, M; Thomine, E; Tron, P; Vannier, JP | 1 |
Aricò, M; Broadbent, V; Gadner, H; Grois, N; Jacobson, A; Komp, D; Ladisch, S; Nicholson, HS | 1 |
D'Angio, GJ | 1 |
Gadner, H; Gatterer-Menz, I; Grois, N; Heitger, A; Ladisch, S | 1 |
Aricò, M; Egeler, RM; Favara, BE; Heitger, A; Neglia, JP; Nesbit, ME | 1 |
Egi, S; Horibe, K; Katayama, I; Kitabayashi, T; Matsushita, T; Miyajima, Y; Numata, S; Sekiguchi, N; Yanai, M | 1 |
Balducci, D; Castello, M; Ceci, A; Colella, R; De Bernardi, B; de Terlizzi, M; Indolfi, P; Loiacono, G; Surico, G; Testi, AM | 1 |
Whitlock, JA | 1 |
Comelli, A; De Bernardi, B; Haupt, R; Rosanda, C; Sessarego, M | 1 |
Fujimoto, J; Meguro, T; Miura, T; Nakamura, M; Tsunematsu, Y; Yamada, K | 1 |
Hirose, M; Kuroda, Y; Saito, S; Yoshimoto, T | 1 |
Boccardi, A; Gandini, G; Krengli, M; Negri, G | 1 |
De Terlizzi, M; Fears, TR; Gadner, H; Haupt, R; Heise, A; Loiacono, G; Tucker, MA | 1 |
Dittert, DD; Fischer, R; Gerlach, B; Richter, G; Stein, A; Wozel, G | 1 |
Hegemann, B; Helmbold, P; Holzhausen, HJ; Klapperstück, T; Marsch, WC | 1 |
de Camargo, B; Lopes, LF | 1 |
Bhargava, V; Das, BK; Datta, V; Kumar, M; Mishra, OP; Singla, PN | 1 |
Aimoni, C; Marangoni, P; Martini, A; Trevisani, M | 1 |
Hsia, SH; Hsueh, C; Hung, IJ; Jaing, TH; Kao, CC; Tain, YL | 1 |
Arico, M; Broadbent, V; Ceci, A; Gadner, H; Grois, N; Jakobson, A; Komp, D; Ladisch, S; Michaelis, J; Nicholson, S; Pötschger, U; Pritchard, J | 1 |
Culić, S; Culić, V; Jakobson, A; Kuzmić, I; Primorac, D; Sćukanec-Spoljar, M | 1 |
Katz, BZ | 1 |
Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A | 1 |
Chu, T | 1 |
Brito, G; Fernandez, T; Klumb, C; Land, MG; Maradei, S; Otero, L; Pombo-de-Oliveira, MS; Silva, ML; Veith, M | 1 |
Inoue, T; Ishii, E; Kajiwara, M; Matsumoto, T; Matsuzaki, A; Miyake, K; Miyazaki, S; Okamura, J; Uozumi, T; Yoshida, N | 1 |
Chu, AC; Thomas, DM; Tsele, E | 1 |
Oliveira, BM; Rios Leite, VH; Silva, CM; Viana, MB | 1 |
Estruch, R; Ingelmo, M; Marrades, RM; Pedrol, E | 1 |
Becchetti, S; Costa, M; Gandus, S; Pinelli, G | 1 |
Chu, AC; Mayou, SC; Munro, DD; Plowman, N | 1 |
Chu, AC; Sheehan, MP | 1 |
Ajarim, DS; al Momen, A; Kyriacou, KC; Santhosh-Kumar, CR; Shipkey, FH | 1 |
Carreño, JC; Hidalgo, R; Moraga, F; Pérez, P; Sánchez de Toledo, J; Teijeiro, AF | 1 |
Broadbent, V; Pritchard, J; Yeomans, E | 1 |
Broadbent, V; Dunger, DB; Grant, DB; Lightman, SL; Pritchard, J; Seckl, JR; Yeoman, E | 1 |
10 review(s) available for etoposide and Hand-Schu00FCller-Christian Disease
Article | Year |
---|---|
An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy.
Topics: Antineoplastic Agents; Central Nervous System; Child; Clinical Trials as Topic; Drug Therapy, Combination; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Prednisolone; Thalidomide; Vinblastine | 2018 |
BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cytoreduction Surgical Procedures; Deglutition Disorders; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Mutation; Prednisone; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Gland; Thyroidectomy | 2019 |
Langerhans's cell histiocytosis in old subjects: two rare case reports and review of the literature.
Topics: Aged; Antigens, CD; Antigens, CD1; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cladribine; Diagnosis, Differential; Erythema; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Lectins, C-Type; Mandibular Diseases; Mannose-Binding Lectins; Mouth Diseases; Palate; Periodontal Diseases; Radiotherapy, Adjuvant; S100 Proteins; Vulvar Diseases | 2012 |
Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Topics: Child; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Promyelocytic, Acute | 1994 |
Treatment of Langerhans cell histiocytosis--evolution and current approaches.
Topics: Biological Factors; Child; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Methylprednisolone; Randomized Controlled Trials as Topic; Remission, Spontaneous; Vinblastine | 1994 |
Multilevel therapeutic targeting by topoisomerase inhibitors.
Topics: Antineoplastic Agents; Cell Cycle; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1994 |
Treatment options--commentary.
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Etoposide; Gene Transfer Techniques; Histiocytosis, Langerhans-Cell; Humans | 1994 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2001 |
Langerhans cell histiocytosis.
Topics: Adult; Antineoplastic Agents, Phytogenic; Biopsy; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis | 2001 |
5 trial(s) available for etoposide and Hand-Schu00FCller-Christian Disease
Article | Year |
---|---|
Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Frontal Bone; Histiocytosis, Langerhans-Cell; Humans; Infant; Interdisciplinary Communication; Male; Neck; Orbit; Parietal Lobe; Patient Care Team; Prednisone; Prognosis; Retrospective Studies; Temporal Bone; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2010 |
LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Topics: Drug Administration Schedule; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Methylprednisolone; Vinblastine | 1994 |
Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine | 1994 |
Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunotherapy; Infant; Infant, Newborn; Italy; Male; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine | 1993 |
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Topics: Adolescent; Child; Drug Therapy, Combination; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Methylprednisolone; Risk Assessment; Survival Analysis; Treatment Outcome; Vinblastine | 2001 |
46 other study(ies) available for etoposide and Hand-Schu00FCller-Christian Disease
Article | Year |
---|---|
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Marrow; Causality; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Langerhans Cells; Laser Capture Microdissection; Middle Aged; Neoplasm Proteins; Point Mutation; Positron-Emission Tomography; Prednisone; Procarbazine; Proto-Oncogene Proteins B-raf; Reed-Sternberg Cells; Temporal Bone; Vincristine | 2018 |
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult | 2016 |
A case of Langerhans cell histiocytosis in an adult with initial symptoms confined to the skin.
Topics: Dexamethasone; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Vinblastine; Young Adult | 2010 |
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2011 |
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transp
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cladribine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Thalidomide; Transplantation, Autologous | 2012 |
Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Vinblastine | 2002 |
Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Interleukin 1 Receptor Antagonist Protein; Male; Predictive Value of Tests; Prednisolone; Receptors, Interleukin-1; Recombinant Proteins; Sialoglycoproteins; Tumor Necrosis Factor-alpha; Vinblastine | 2003 |
Commenting on "Vulvar langerhans cell histocytosis: a case report and review of the literature" by Santillan et al. 91:241-246.
Topics: Child, Preschool; Combined Modality Therapy; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Neoplasm Recurrence, Local; Vinblastine; Vulvar Diseases | 2004 |
[Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Vinblastine | 2005 |
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Female; Graft Survival; Histiocytosis, Langerhans-Cell; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Melphalan; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Vinblastine | 2007 |
Adult Langerhans cell histiocytosis with independently relapsing lung and liver lesions that was successfully treated with etoposide.
Topics: Adult; Antineoplastic Agents, Phytogenic; Biopsy; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Liver; Liver Diseases; Lung; Lung Diseases; Male; Secondary Prevention | 2007 |
[Langerhans' cell histiocytosis of the dorsal spine. A rare etiology of spinal cord compression].
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Fatal Outcome; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraparesis, Spastic; Spinal Cord Compression; Spinal Diseases; Thoracic Vertebrae; Vinblastine | 2008 |
Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
Topics: Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic | 1994 |
VP-16 and the treatment of histiocytosis.
Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute | 1994 |
Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
Topics: Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant | 1994 |
Langerhans cell histiocytosis in an adult.
Topics: Administration, Topical; Adult; Axilla; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Mechlorethamine; Methotrexate; Scalp | 1994 |
[Langerhans-cell histiocytosis in twin sisters].
Topics: Diseases in Twins; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Twins, Monozygotic; Vinblastine | 1994 |
Langerhans cell histiocytosis and etoposide: risks vs. benefits.
Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 1994 |
Acute leukemia in association with Langerhans cell histiocytosis.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Retrospective Studies; Surveys and Questionnaires; Vinblastine; Vincristine | 1994 |
Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Topics: Child, Preschool; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Leukemia, Promyelocytic, Acute; Translocation, Genetic | 1993 |
Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al.
Topics: Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 1993 |
Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone.
Topics: Acute Disease; Bone Diseases; Child; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid; Translocation, Genetic | 1993 |
Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
Topics: Afibrinogenemia; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Prednisolone; Radiography | 1993 |
Interleukin-2 therapy of Langerhans cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-CD8 Ratio; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Interleukin-2; Killer Cells, Natural; Prednisolone; Receptors, IgG; Remission Induction; Vindesine | 1995 |
[Report of a rare case of Langerhans-cell histiocytosis of the skull base].
Topics: Adult; Antineoplastic Agents, Phytogenic; Cobalt Radioisotopes; Etoposide; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Prognosis; Radiotherapy Dosage; Skull; Sphenoid Bone; Temporal Bone; Time Factors; Tomography, X-Ray Computed | 1996 |
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Topics: Adolescent; Adult; Age Factors; Austria; Child; Child, Preschool; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cohort Studies; Etoposide; Female; Follow-Up Studies; Germany; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Italy; Leukemia, Myeloid, Acute; Male; Netherlands; Risk Assessment; Sex Factors; Switzerland; Translocation, Genetic | 1997 |
[Langerhans cell histiocytosis in the elderly].
Topics: Adult; Aged; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunoenzyme Techniques; Liver Diseases; Mechlorethamine; Microscopy, Electron; Recurrence; Skin; Treatment Failure | 1998 |
Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Chronic Disease; Drug Administration Schedule; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Male | 1998 |
Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH)
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Promyelocytic, Acute; Male | 1999 |
Class I histiocytosis: response to combination of etoposide and prednisolone.
Topics: Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Infant; Injections, Intravenous; Male; Nucleic Acid Synthesis Inhibitors; Prednisolone; Remission Induction | 1999 |
Langerhans' cell histiocytosis: report of a case with temporal localization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Clinical Protocols; Etoposide; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Male; Skull Neoplasms; Steroids; Temporal Bone; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration.
Topics: Acute Kidney Injury; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Blood Transfusion; Combined Modality Therapy; Disease Progression; Etoposide; Fatal Outcome; Female; Fluid Therapy; Hemofiltration; Histiocytosis, Langerhans-Cell; Humans; Infant; L-Lactate Dehydrogenase; Lymph Nodes; Mercaptopurine; Multiple Organ Failure; Neck; Orbital Diseases; Prednisolone; Sodium Bicarbonate; Temporal Bone; Tumor Lysis Syndrome; Uric Acid; Vinblastine; Vincristine | 2001 |
Etoposide as the basic and interferon-alpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC.
Topics: Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytomegalovirus; Etoposide; Female; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Infant; Interferon-alpha; Remission Induction; S100 Proteins | 2001 |
Treatment for multisystem Langerhans' cell histiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Nucleic Acid Synthesis Inhibitors; Vinblastine | 2002 |
Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Neoplasms, Second Primary; Nuclear Pore Complex Proteins; Prednisolone; Topoisomerase II Inhibitors; Translocation, Genetic; Vinblastine | 2002 |
Treatment of Langerhans cell histiocytosis in children with etoposide.
Topics: Adolescent; Child; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Remission Induction | 1992 |
Treatment of adult Langerhans cell histiocytosis with etoposide.
Topics: Adult; Drug Administration Schedule; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infusions, Intravenous; Male; Middle Aged | 1992 |
Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)
Topics: Child, Preschool; Drug Administration Schedule; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Immunologic Deficiency Syndromes; Infant; Langerhans Cells; Male; Recurrence; Remission Induction | 1991 |
[Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
Topics: Adult; Drug Administration Schedule; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Male | 1991 |
Langerhans' cell histiocytosis: a case report.
Topics: Child; Combined Modality Therapy; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Ilium; Osteolysis; Tomography, X-Ray Computed | 1991 |
Langerhans-cell histiocytosis--excellent response to etoposide.
Topics: Adult; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Male; Skin | 1991 |
Oral, skin and bone multisystem Langerhans cell histiocytosis and its response to etoposide--a case report.
Topics: Adolescent; Bone Diseases; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Male; Mouth Diseases; Skin Diseases | 1991 |
Unusual skin tumors in Langerhans' cell histiocytosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Male; Neoplasms, Multiple Primary; Prednisone; Skin Neoplasms | 1990 |
Clinical and radiographic response of Langerhans' cell histiocytosis with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Osteolysis; Radiography; Vinblastine | 1990 |
Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
Topics: Adolescent; Child; Child, Preschool; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Infant; Steroids | 1989 |
The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
Topics: Adolescent; Arginine Vasopressin; Blepharoptosis; Child; Child, Preschool; Diabetes Insipidus; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Pituitary Gland, Posterior; Prednisolone; Prospective Studies; Time Factors | 1989 |